Tim Grob

Tim Grob is a Researcher in Hematology at Erasmus University Medical Center. His work focuses on molecular stratification of acute myeloid leukemia, particularly genomic approaches for minimal residual disease detection. He develops next-generation sequencing assays for mutation-specific monitoring of NPM1, FLT3-ITD, and CEBPA variants.

Research demonstrates clinical utility of residual disease monitoring for relapse prediction and treatment optimization. Recent studies characterize high-risk DNMT3A double-mutant AML subtypes with poor prognosis.